Peter Evan Harwin - Net Worth and Insider Trading

Over the past 18 months, Peter Evan Harwin made no insider transaction in Cogent Biosciences Inc (COGT). Other recent insider transactions involving Cogent Biosciences Inc (COGT) include a net purchase of 800,000 shares made by Fairmount Funds Management Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Cogent Biosciences Inc (COGT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cogent Biosciences Inc (COGT) were sold and 800,000 shares were bought by its insiders, resulting in a net purchase of 800,000 shares.

Cogent Biosciences Inc (COGT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter Evan Harwin made no insider transaction in Mirati Therapeutics Inc (MRTX). Other recent insider transactions involving Mirati Therapeutics Inc (MRTX) include a net sale of 16,852 shares made by Jamie Christensen , a net sale of 12,809 shares made by Benjamin Hickey , and a net sale of 81,996 shares made by Charles M Baum .

In summary, during the past 3 months, insiders sold 0 shares of Mirati Therapeutics Inc (MRTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 126,645 shares of Mirati Therapeutics Inc (MRTX) were sold and 2,528,737 shares were bought by its insiders, resulting in a net purchase of 2,402,092 shares.

Mirati Therapeutics Inc (MRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter Evan Harwin made no insider transaction in Viridian Therapeutics Inc (VRDN). Other recent insider transactions involving Viridian Therapeutics Inc (VRDN) include a net sale of 89,514 shares made by Lara Meisner , a net sale of 100,000 shares made by Jonathan Violin , and a net sale of 89,000 shares made by Barrett Katz .

In summary, during the past 3 months, insiders sold 0 shares of Viridian Therapeutics Inc (VRDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 278,514 shares of Viridian Therapeutics Inc (VRDN) were sold and 485,690 shares were bought by its insiders, resulting in a net purchase of 207,176 shares.

Viridian Therapeutics Inc (VRDN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Spyre Therapeutics Inc (SYRE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spyre Therapeutics Inc (SYRE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Spyre Therapeutics Inc (SYRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter Evan Harwin made no insider transaction in Apogee Therapeutics Inc (APGE). Other recent insider transactions involving Apogee Therapeutics Inc (APGE) include a net purchase of 2,941,176 shares made by Fairmount Healthcare Fund L.p. , and a net purchase of 1,750,000 shares made by Nimish P Shah .

In summary, during the past 3 months, insiders sold 0 shares of Apogee Therapeutics Inc (APGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Apogee Therapeutics Inc (APGE) were sold and 4,691,176 shares were bought by its insiders, resulting in a net purchase of 4,691,176 shares.

Apogee Therapeutics Inc (APGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Peter Evan Harwin made no insider transaction in Magenta Therapeutics Inc (MGTA). Other recent insider transactions involving Magenta Therapeutics Inc (MGTA) include a net sale of 3,700,000 shares made by Third Rock Ventures Iv, L.p. ,

In summary, during the past 3 months, insiders sold 0 shares of Magenta Therapeutics Inc (MGTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,700,000 shares of Magenta Therapeutics Inc (MGTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,700,000 shares.

Magenta Therapeutics Inc (MGTA)'s detailed insider trading history can be found in Insider Trading Tracker table.